Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis - PubMed (original) (raw)

Review

Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis

Motoharu Seiki et al. Cancer Sci. 2003 Jul.

Abstract

Behavior of cancer cells is profoundly affected by their microenvironment, which is often controlled by pericellular proteolysis or the processing of protein components, including extracellular matrices, growth factors, cytokines, receptors, cell adhesion molecules, and so on. Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteases responsible for the proteolytic events in the extracellular milieu. Among the multiple MMPs expressed in a wide range of tumors, membrane type-1 MMP (MT1-MMP), which is expressed especially in tumor cells with significant invasive properties, is thought to be particularly important for pericellular proteolysis. Recent studies have elucidated in part how MT1-MMP is regulated biologically for the promotion of invasion by tumors or for angiogenesis by endothelial cells. Understanding of the proteolysis by, and the regulation of MT1-MMP, which probably promotes cell invasion, could provide a therapeutic hint as to how to block or delay the progression of cancer.

PubMed Disclaimer

Cited by

Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance.
Mazumder S, Higgins PJ, Samarakoon R. Mazumder S, et al. Cancers (Basel). 2023 Feb 19;15(4):1316. doi: 10.3390/cancers15041316. Cancers (Basel). 2023. PMID: 36831657 Free PMC article. Review.
Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.
Arshad JZ, Hanif M. Arshad JZ, et al. RSC Med Chem. 2022 Jul 29;13(10):1127-1149. doi: 10.1039/d2md00175f. eCollection 2022 Oct 19. RSC Med Chem. 2022. PMID: 36325396 Free PMC article. Review.
Expression of Inflammatory Mediators in Periodontitis Over Established Diabetes: an Experimental Study in Rats.
Choubaya C, Chahine N, Aoun G, Anil S, Zalloua P, Salameh Z. Choubaya C, et al. Med Arch. 2021 Dec;75(6):436-443. doi: 10.5455/medarh.2021.75.436-443. Med Arch. 2021. PMID: 35169371 Free PMC article.
Cell-Scale Degradation of Peritumoural Extracellular Matrix Fibre Network and Its Role Within Tissue-Scale Cancer Invasion.
Shuttleworth R, Trucu D. Shuttleworth R, et al. Bull Math Biol. 2020 May 26;82(6):65. doi: 10.1007/s11538-020-00732-z. Bull Math Biol. 2020. PMID: 32458057 Free PMC article.
MT1-MMP recruits the ER-Golgi SNARE Bet1 for efficient MT1-MMP transport to the plasma membrane.
Miyagawa T, Hasegawa K, Aoki Y, Watanabe T, Otagiri Y, Arasaki K, Wakana Y, Asano K, Tanaka M, Yamaguchi H, Tagaya M, Inoue H. Miyagawa T, et al. J Cell Biol. 2019 Oct 7;218(10):3355-3371. doi: 10.1083/jcb.201808149. Epub 2019 Sep 13. J Cell Biol. 2019. PMID: 31519727 Free PMC article.

References

1. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2001; 2: 163–76. - PubMed
1. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999; 284: 808–12. - PubMed
1. Tryggvason K, Hoyhtya M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat 1993; 24: 209–18. - PubMed
1. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61–5. - PubMed
1. Cao J, Sato H, Takino T, Seiki M. The C‐terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro‐gelatinase A activation. J Biol Chem 1995; 270: 801–5. - PubMed

Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis - PubMed (original) (raw)